AeroLeads people directory · profile

Ron Cooper Email & Phone Number

Chief Executive Officer | Member, Board of Directors at enGene

Location: Boston, Massachusetts, United States 15 work roles 1 school

2 work emails found @albireopharma.com 4 phones found area 732, 857, and 203 LinkedIn matched

✓ Verified Jun 2026 4 data sources Profile completeness 100%

Current company

enGene

Role

Chief Executive Officer | Member, Board of Directors

Location

Boston, Massachusetts, United States

Company size

131 employees

Who is Ron Cooper? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Ron Cooper is listed as Chief Executive Officer | Member, Board of Directors at enGene, a company with 131 employees, based in Boston, Massachusetts, United States. AeroLeads shows a work email signal at albireopharma.com, phone signal with area code 732, 857, 203, and a matched LinkedIn profile for Ron Cooper.

Ron Cooper previously worked as Chairman of the Board at C4 Therapeutics, Inc. and Board Member and Chair of the Nomination & Governance Committee at Generation Bio. Ron Cooper holds Bachelor Of Science - Bsc, Chemistry And Business Administration from St. Francis Xavier University.

Company email context

Email format at enGene

This section adds company-level context without repeating Ron Cooper's masked contact details.

{first}.{last}@albireopharma.com

89% confidence

AeroLeads found 2 current-domain work email signals for Ron Cooper. Compare company email patterns before reaching out.

View email format View company profile Management contacts

Profile bio

About Ron Cooper

As the CEO and board member of a “start-to-finish” biotech entrepreneurial venture and at-scale Fortune 100 pharma career, Ron Cooper has deep global expertise honed from working and living in five different countries. He is a mission-focused, strategic leader who has run multi-billion dollar global businesses and transacted his biotech for over $1B in value. Ron brings a unique perspective and approach in creating significant impact and delivering superior results. He architected and drove a strategic reinvention that turned a largely unknown, private, Swedish R&D-stage biotech into a NASDAQ listed, high-value organization. In addition, Ron played a pivotal role in the US and European approval of Bylvay, the first drug approved for a rare pediatric liver disease. While in big pharma, he propelled a >$4.5B recession-ravaged business through a major turnaround, erasing a 5% decline and generating 30% profit growth. With his deep experience, Ron is an asset to boards of biotech companies as an advisor on drug development, financing strategy, resource allocation, and commercial viability. He is a board member and committee chair at Generation Bio, a non-viral gene therapy company. Ron is a past director at Albireo Pharma and Genocea Biosciences, having served on every main board committee.

Listed skills include Pharmaceutical Industry, Product Launch, Pharmaceutical Sales, Strategy, and 20 others.

Current workplace

Ron Cooper's current company

Company context helps verify the profile and gives searchers a useful next step.

Engene

Chief Executive Officer | Member, Board of Directors

Boston, MA, US

Website

engene.com

Employees

131

AeroLeads page

Company profile

View company profile Email format

15 roles

Ron Cooper work experience

A career timeline built from the work history available for this profile.

Chief Executive Officer | Member, Board Of Directors

Engene

Boston, MA, US

Chairman Of The Board

C4 Therapeutics, Inc.

Watertown, MA, US

Board Chairman of a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives.

Board Member And Chair Of The Nomination & Governance Committee

Generation Bio

Cambridge, Massachusetts, US

Board Member and Chair of the Nominating & Governance Committee of this innovative biotech preclinical company creating a new class of non-viral genetic medicines, treating a wide range of both rare and prevalent diseases.

President & Chief Executive Officer | Member, Board Of Directors

Albireo Pharma, Inc.

Grew a small private early-phase European R&D organization to a fully integrated global commercial NASDAQ listed biotech (NASDAQ: ALBO), driving value from ~$50M to >$1B. Raised more than $850M by executing 14 wide-ranging, transformative financial transactions with nearly 50% non-dilutive capital. Built a top-quality new executive team, transitioning.

Jun 2015 - Mar 2023

Board Member

Genocea Biosciences

Board Member and Member of Audit, Compensation, and Nominating & Governance Committees that sought to harness T-cell immunity to develop novel vaccines and immunotherapies.

Jun 2016 - Apr 2021

President, Europe

Bristol Myers Squibb

Colleagues at enGene

Other employees you can reach at engene.com. View company contacts for 131 employees →

DL

David Lazure Colleague at EngeneQuebec, Canada, Canada View → DV

Daniel Veilleux Colleague at EngeneMontreal, Quebec, Canada, Canada View → ZM

Zamo Marvelous Des Colleague at EngeneDurban, KwaZulu-Natal, South Africa, South Africa View → DG

David Gareau Colleague at EngeneGreater Montreal Metropolitan Area, Canada View → ML

Mini Lisa Colleague at EngeneCity Of Cape Town, Western Cape, South Africa, South Africa View → TP

Tara Place, Mba Colleague at EngeneGreater Boston, United States View → MK

Miko Kiluh Colleague at EngeneGreater Marseille Metropolitan Area, France View → HN

Hassan Nasser Colleague at EngeneYemen, Yemen View → BH

Brooks Handey Colleague at EngeneBirmingham, Alabama, United States, United States View → ST

Smit Tom Colleague at EngeneIndia, India View →

1 education record

Ron Cooper education

St. Francis Xavier University

Chemistry And Business Administration

FAQ

Frequently asked questions about Ron Cooper

Quick answers generated from the profile data available on this page.

What company does Ron Cooper work for?

Ron Cooper works for enGene.

What is Ron Cooper's role at enGene?

Ron Cooper is listed as Chief Executive Officer | Member, Board of Directors at enGene.

What is Ron Cooper's email address?

AeroLeads has found 2 work email signals at @albireopharma.com for Ron Cooper at enGene.

What is Ron Cooper's phone number?

AeroLeads has found 4 phone signal(s) with area code 732, 857, 203 for Ron Cooper at enGene.

Where is Ron Cooper based?

Ron Cooper is based in Boston, Massachusetts, United States while working with enGene.

What companies has Ron Cooper worked for?

Ron Cooper has worked for Engene, C4 Therapeutics, Inc., Generation Bio, Albireo Pharma, Inc., and Genocea Biosciences.

Who are Ron Cooper's colleagues at enGene?

Ron Cooper's colleagues at enGene include David Lazure, Daniel Veilleux, Zamo Marvelous Des, David Gareau, and Mini Lisa.

How can I contact Ron Cooper?

You can use AeroLeads to view verified contact signals for Ron Cooper at enGene, including work email, phone, and LinkedIn data when available.

What schools did Ron Cooper attend?

Ron Cooper holds Bachelor Of Science - Bsc, Chemistry And Business Administration from St. Francis Xavier University.

What skills is Ron Cooper known for?

Ron Cooper is listed with skills including Pharmaceutical Industry, Product Launch, Pharmaceutical Sales, Strategy, Biotechnology, Cross Functional Team Leadership, Leadership, and Oncology.

Security Check